CCRB Logo

Trial History Detail on 2009-11-27

CUHK_CCT00063

2005-09-12

Retrospective

n/a

N/A

Roche

n/a

Benny Fok

Department of Medicine and Therapeutics

26323377

bfok@cuhk.edu.hk

The Chinese University of Hong Kong

Brian Tomlinson

Department of Medicine and Therapeutics

26323139

btomlinson@cuhk.edu.hk

The Chinese University of Hong Kong

A placebo controlled, randomized study to examine the impact of 24-week orlistat treatment on postprandial triglyceridaemia, steatohepatitis and cardiovascular risk factors in overweight Chinese patients

A placebo controlled, randomized study to examine the impact of 24-week orlistat treatment on postprandial triglyceridaemia, steatohepatitis and cardiovascular risk factors in overweight Chinese patients

n/a

Hong Kong

Yes

2003-11-04

Obesity

Drug

Orlistat

24 weeks

Placebo

Chinese patients with obesity and dyslipidaemia

Patients on orlistat within one month prior to study

18

78

Both Male and Female

Interventional

Randomized

Placebo

Double-blind

Parallel

2004-01-01

40

Complete

Postprandial triglyceridaemia, visceral and hepatic fat deposition

Body weight, cardiovascular risk profiles

No

2009-11-27


Yes

Type Access Document Published On  
No documents yet.
  • Page 1 of 1.